LMR Partners’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
Other funds holding ORIC
LMR Partners's ORIC Position: Q3 2026 in Review
LMR Partners held its Oric Pharmaceuticals (ORIC) position steady in Q3 2026 at 35,267 shares worth $475K. The position accounts for ﹤0.01% of the portfolio, ranked #1222.
LMR Partners first reported a position in ORIC in Q2 2022 and has held it in 10 quarters since. 203 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.
- LMR Partners held 35,267 shares of Oric Pharmaceuticals worth $475K as of Q3 2026.
- LMR Partners left its Oric Pharmaceuticals share count unchanged in Q3 2026.
- Oric Pharmaceuticals made up ﹤0.01% of LMR Partners's portfolio in Q3 2026, its #1222 holding.
- LMR Partners first reported a position in Oric Pharmaceuticals in Q2 2022 and has held it in 10 quarters since.
- 203 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.
Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.